Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshimasa Inoue

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Experimental and Therapeutic Medicine|September 13, 2012
Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 geneHitoshi Yamazaki, Tsuyoshi Chijiwa, Yoshimasa Inoue, et al.
Oncology Reports|November 4, 2009
Alternative splicing variant of vascular endothelial growth factor-A is a critical prognostic factor in non-small cell lung cancerMasahiro Matsuyama, Tsuyoshi Chijiwa, Yoshimasa Inoue, et al.
Therapeutic Drug Monitoring|December 11, 2020
Effects of CYP2D6 Genotypes on Venlafaxine Metabolism in Japanese Psychiatric Patients With DepressionHazuki Komahashi-Sasaki, Norio Yasui-Furukori, Taro Sasaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
Use of 11p15 mucins as prognostic factors in small adenocarcinoma of the lungNoboru Nishiumi, Yoshiyuki Abe, Yoshimasa Inoue, et al.
International Journal of Oncology|July 16, 2004
The subunits of glutamate cysteine ligase enhance cisplatin resistance in human non-small cell lung cancer xenografts in vivoSakashi Fujimori, Yoshiyuki Abe, Masatake Nishi, et al.
International Journal of Oncology|October 9, 2003
The modifier subunit of glutamate cysteine ligase (GCLM) is a molecular target for amelioration of cisplatin resistance in lung cancerYoshimasa Inoue, Masashi Tomisawa, Hitoshi Yamazaki, et al.
Plos One|March 2, 2013
Telmisartan inhibits cell proliferation by blocking nuclear translocation of ProHB-EGF C-terminal fragment in colon cancer cellsKeiji Ozeki, Satoshi Tanida, Chie Morimoto, et al.
Pharmacopsychiatry|June 4, 2019
8-Hydroxylation and Glucuronidation of Mirtazapine in Japanese Psychiatric Patients: Significance of the Glucuronidation Pathway of 8-Hydroxy-MirtazapineMasataka Shinozaki, Jason Pierce, Yuki Hayashi, et al.
Bioorganic & Medicinal Chemistry|January 9, 2003
Synthesis and structure-activity relationships of 5,6,7,8-tetrahydropyrido[3,4-b]pyrazine-based hydroxamic acids as HB-EGF shedding inhibitorsKazuya Yoshiizumi, Minoru Yamamoto, Tomohiro Miyasaka, et al.
The Primary Care Companion for CNS Disorders|October 30, 2012
A case of drug overdose-induced, severe electrocardiogram abnormalities: investigation through plasma drug concentrationsKatsumi Sanjo, Atsuhiko Koeda, Noritaka Koizumi, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Experimental and Therapeutic Medicine|September 13, 2012
Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 geneHitoshi Yamazaki, Tsuyoshi Chijiwa, Yoshimasa Inoue, et al.
Oncology Reports|November 4, 2009
Alternative splicing variant of vascular endothelial growth factor-A is a critical prognostic factor in non-small cell lung cancerMasahiro Matsuyama, Tsuyoshi Chijiwa, Yoshimasa Inoue, et al.
Therapeutic Drug Monitoring|December 11, 2020
Effects of CYP2D6 Genotypes on Venlafaxine Metabolism in Japanese Psychiatric Patients With DepressionHazuki Komahashi-Sasaki, Norio Yasui-Furukori, Taro Sasaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
Use of 11p15 mucins as prognostic factors in small adenocarcinoma of the lungNoboru Nishiumi, Yoshiyuki Abe, Yoshimasa Inoue, et al.
International Journal of Oncology|July 16, 2004
The subunits of glutamate cysteine ligase enhance cisplatin resistance in human non-small cell lung cancer xenografts in vivoSakashi Fujimori, Yoshiyuki Abe, Masatake Nishi, et al.
International Journal of Oncology|October 9, 2003
The modifier subunit of glutamate cysteine ligase (GCLM) is a molecular target for amelioration of cisplatin resistance in lung cancerYoshimasa Inoue, Masashi Tomisawa, Hitoshi Yamazaki, et al.
Plos One|March 2, 2013
Telmisartan inhibits cell proliferation by blocking nuclear translocation of ProHB-EGF C-terminal fragment in colon cancer cellsKeiji Ozeki, Satoshi Tanida, Chie Morimoto, et al.
Pharmacopsychiatry|June 4, 2019
8-Hydroxylation and Glucuronidation of Mirtazapine in Japanese Psychiatric Patients: Significance of the Glucuronidation Pathway of 8-Hydroxy-MirtazapineMasataka Shinozaki, Jason Pierce, Yuki Hayashi, et al.
Bioorganic & Medicinal Chemistry|January 9, 2003
Synthesis and structure-activity relationships of 5,6,7,8-tetrahydropyrido[3,4-b]pyrazine-based hydroxamic acids as HB-EGF shedding inhibitorsKazuya Yoshiizumi, Minoru Yamamoto, Tomohiro Miyasaka, et al.
The Primary Care Companion for CNS Disorders|October 30, 2012
A case of drug overdose-induced, severe electrocardiogram abnormalities: investigation through plasma drug concentrationsKatsumi Sanjo, Atsuhiko Koeda, Noritaka Koizumi, et al.
Pageof 10